Challenges in predicting the need for coronary artery bypass grafting at presentation in patients with non-ST-segment elevation acute coronary syndromes

被引:36
|
作者
Mehta, Rajendra H. [1 ]
Chen, Anita Y.
Pollack, Charles V., Jr.
Roe, Matthew T.
Zalenski, Robert J.
Clements, Elizabeth A.
Gibler, W. Brian
Ohman, E. Magnus
Harrington, Robert A.
Peterson, Eric D.
机构
[1] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA
[2] Univ Penn, Sch Med, Penn Hosp, Philadelphia, PA 19104 USA
[3] Wayne State Univ, Sch Med, Detroit, MI USA
[4] Spectrum Hlth, Dept Pharm Serv, Grand Rapids, MI USA
[5] Univ Cincinnati, Sch Med, Cincinnati, OH USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2006年 / 98卷 / 05期
关键词
D O I
10.1016/j.amjcard.2006.03.040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the case of non-ST-segment elevation acute coronary syndromes (NSTE-ACSs), the acute use of certain antiplatelet agents is complicated by concerns about perioperative bleeding risks in patients requiring coronary artery bypass grafting (CABG) during the index hospitalization. As a result, clinicians often withhold potentially useful agents, such as clopidogrel, before determining patients' coronary anatomy. An accurate predictive model could allow for a better balance of this safety concern with the demonstrated benefits of agents such as clopidogrel. To create an accurate decision-making tool that would assess, at hospital presentation, the need for CABG in patients with NSTE-ACSs, we studied 61,974 high-risk patients with NSTE-ACS admitted to 311 CABG-capable hospitals participating in Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines (CRUSADE) from 2001 to 2003. A total of 8,395 patients (14%) underwent CABG during their initial hospital stay. A multivariate model was developed and identified 13 presenting clinical characteristics significantly associated with the likelihood of CABG (previous CABG, male gender, previous heart failure, diabetes, hyperlipidemia, renal insufficiency, ST depression and transient ST elevation, age 75 years, previous percutaneous coronary intervention, family history of coronary artery disease, hypertension, trends in CABG rates, and previous stroke). This model had only modest predictive accuracy and calibration (c-index = 0.67). In conclusion, although certain presenting clinical features are associated with an increased likelihood of CABG in patients with NSTE-ACSs during the index hospitalization, it remains difficult to reliably identify, before diagnostic angiography, those who will subsequently undergo surgical revascularization. (c) 2006 Elsevier Inc.
引用
收藏
页码:624 / 627
页数:4
相关论文
共 50 条
  • [41] Triple antiplatelet treatment in patients presenting with non-ST-segment elevation acute coronary syndromes
    Bertrand, Michel E.
    Van Belle, Eric
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2006, 8 (0G) : G59 - G63
  • [42] Ranolazine: a new antiarrhythmic agent for patients with non-ST-segment elevation acute coronary syndromes?
    Charles Antzelevitch
    Nature Clinical Practice Cardiovascular Medicine, 2008, 5 : 248 - 249
  • [43] Avoidance of routine revascularization in the management of patients with non-ST-segment elevation acute coronary syndromes
    Boden, WE
    AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (12B): : 42M - 47M
  • [44] Early invasive strategy in diabetic patients with non-ST-segment elevation acute coronary syndromes
    Baeza Roman, Anna
    Latour Perez, Jaime
    de Miguel Balsa, Eva
    Pino Izquierdo, Karel
    Coves Orts, Francisco Javier
    Garcia Ochando, Luis
    de la Torre Fernandez, Maria Jose
    MEDICINA CLINICA, 2014, 142 (10): : 427 - 431
  • [45] Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes
    Rao, Sunil V.
    Eikelboom, John A.
    Granger, Christopher B.
    Harrington, Robert A.
    Califf, Robert M.
    Bassand, Jean-Pierre
    EUROPEAN HEART JOURNAL, 2007, 28 (10) : 1193 - 1204
  • [46] Impact of congestive heart failure in patients with non-ST-segment elevation acute coronary syndromes
    Roe, MT
    Chen, AY
    Riba, AL
    Goswami, RG
    Peacock, WF
    Pollack, CV
    Collins, SP
    Gibler, WB
    Ohman, EM
    Peterson, ED
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (12): : 1707 - 1712
  • [47] Avoiding and Managing Bleeding Complications in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes
    Potsis, Thomas Z.
    Katsouras, Christos
    Goudevenos, John A.
    ANGIOLOGY, 2009, 60 (02) : 148 - 158
  • [48] Ranolazine: a new antiarrhythmic agent for patients with non-ST-segment elevation acute coronary syndromes?
    Antzelevitch, Charles
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2008, 5 (05): : 248 - 249
  • [49] Antithrombotic therapy in medically managed patients with non-ST-segment elevation acute coronary syndromes
    Gurbel, Paul A.
    Tantry, Udaya S.
    HEART, 2016, 102 (11) : 882 - U101
  • [50] Antiplatelet and antithrombin dose variation in patients with non-ST-segment elevation acute coronary syndromes
    Alexander, KP
    Chen, AY
    T Roe, M
    Newby, LK
    Gibler, WB
    Ohman, EM
    Peterson, ED
    CIRCULATION, 2005, 111 (20) : E312 - E313